APO Research
Talk to an analyst

APO RESEARCH · REPORT

TACE Embolic Microspheres

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global TACE Embolic Microspheres Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchTACE Embolic Microspheres Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal TACE Embolic Microspheres Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal TACE Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TACE Embolic Microspheres Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal TACE Embolic Microspheres Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global TACE Embolic Microspheres market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the TACE Embolic Microspheres market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the TACE Embolic Microspheres market include ABK Biomedical, Boston Scientific, Merit Medical, Mermaid Medical, Sirtex Medical, Terumo, Varian, Cardiolink Science and Suzhou Hengrui Medical Equipment, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global TACE Embolic Microspheres market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of TACE Embolic Microspheres and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents TACE Embolic Microspheres sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the TACE Embolic Microspheres market size, projected growth trends, production technologies, key applications, and end-use industries.

TACE Embolic Microspheres Segment by Company

ABK Biomedical

Boston Scientific

Merit Medical

Mermaid Medical

Sirtex Medical

Terumo

Varian

Cardiolink Science

Suzhou Hengrui Medical Equipment

TACE Embolic Microspheres Segment by Type

Common Embolic Microspheres

Drug-Loadable Embolic Microspheres

TACE Embolic Microspheres Segment by Application

Colorectal Cancer Liver Metastasis

Primary Liver Cancer

Others

TACE Embolic Microspheres Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global TACE Embolic Microspheres status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions TACE Embolic Microspheres market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify TACE Embolic Microspheres significant trends, drivers, influence factors in global and regions.

6. To analyze TACE Embolic Microspheres competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TACE Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TACE Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TACE Embolic Microspheres.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the TACE Embolic Microspheres market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global TACE Embolic Microspheres industry.

Chapter 3: Detailed analysis of TACE Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of TACE Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of TACE Embolic Microspheres in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. TACE Embolic Microspheres Industry Trends Table 2. TACE Embolic Microspheres Industry Drivers Table 3. TACE Embolic Microspheres Industry Opportunities and Challenges Table 4. TACE Embolic Microspheres Industry Restraints Table 5. Global TACE Embolic Microspheres Revenue by Company (US$ Million) & (2021-2026) Table 6. Global TACE Embolic Microspheres Revenue Share by Company (2021-2026) Table 7. Global TACE Embolic Microspheres Sales Volume by Company (K Units) & (2021-2026) Table 8. Global TACE Embolic Microspheres Sales Volume Share by Company (2021-2026) Table 9. Global TACE Embolic Microspheres Average Price (US$/Unit) of Company (2021-2026) Table 10. Global TACE Embolic Microspheres Company Ranking, (2024-2026) & (USD Million) Table 11. Global TACE Embolic Microspheres Key Company Manufacturing Base & Headquarters Table 12. Global TACE Embolic Microspheres Company, Product Type & Application Table 13. Global TACE Embolic Microspheres Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global TACE Embolic Microspheres by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Common Embolic Microspheres Table 18. Significant Companies of Drug-Loadable Embolic Microspheres Table 19. Global TACE Embolic Microspheres Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global TACE Embolic Microspheres Sales Volume by Type (2021-2026) & (K Units) Table 21. Global TACE Embolic Microspheres Sales Volume by Type (2027-2032) & (K Units) Table 22. Global TACE Embolic Microspheres Sales Volume Share by Type (2021-2026) Table 23. Global TACE Embolic Microspheres Sales Volume Share by Type (2027-2032) Table 24. Global TACE Embolic Microspheres Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global TACE Embolic Microspheres Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global TACE Embolic Microspheres Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global TACE Embolic Microspheres Sales Value Share by Type (2021-2026) Table 28. Global TACE Embolic Microspheres Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Colorectal Cancer Liver Metastasis Table 30. Significant Companies of Primary Liver Cancer Table 31. Significant Companies of Others Table 32. Global TACE Embolic Microspheres Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global TACE Embolic Microspheres Sales Volume by Application (2021-2026) & (K Units) Table 34. Global TACE Embolic Microspheres Sales Volume by Application (2027-2032) & (K Units) Table 35. Global TACE Embolic Microspheres Sales Volume Share by Application (2021-2026) Table 36. Global TACE Embolic Microspheres Sales Volume Share by Application (2027-2032) Table 37. Global TACE Embolic Microspheres Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global TACE Embolic Microspheres Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global TACE Embolic Microspheres Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global TACE Embolic Microspheres Sales Value Share by Application (2021-2026) Table 41. Global TACE Embolic Microspheres Sales Value Share by Application (2027-2032) Table 42. Global TACE Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global TACE Embolic Microspheres Sales by Region (2021-2026) & (K Units) Table 44. Global TACE Embolic Microspheres Sales Market Share by Region (2021-2026) Table 45. Global TACE Embolic Microspheres Sales by Region (2027-2032) & (K Units) Table 46. Global TACE Embolic Microspheres Sales Market Share by Region (2027-2032) Table 47. Global TACE Embolic Microspheres Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global TACE Embolic Microspheres Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global TACE Embolic Microspheres Sales Value Share by Region (2021-2026) Table 50. Global TACE Embolic Microspheres Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global TACE Embolic Microspheres Sales Value Share by Region (2027-2032) Table 52. Global TACE Embolic Microspheres Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global TACE Embolic Microspheres Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global TACE Embolic Microspheres Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global TACE Embolic Microspheres Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global TACE Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 57. Global TACE Embolic Microspheres Sales Market Share by Country (2021-2026) Table 58. Global TACE Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 59. Global TACE Embolic Microspheres Sales Market Share by Country (2027-2032) Table 60. Global TACE Embolic Microspheres Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global TACE Embolic Microspheres Sales Value Market Share by Country (2021-2026) Table 62. Global TACE Embolic Microspheres Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global TACE Embolic Microspheres Sales Value Market Share by Country (2027-2032) Table 64. ABK Biomedical Company Information Table 65. ABK Biomedical Business Overview Table 66. ABK Biomedical TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. ABK Biomedical TACE Embolic Microspheres Product Portfolio Table 68. ABK Biomedical Recent Development Table 69. Boston Scientific Company Information Table 70. Boston Scientific Business Overview Table 71. Boston Scientific TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Boston Scientific TACE Embolic Microspheres Product Portfolio Table 73. Boston Scientific Recent Development Table 74. Merit Medical Company Information Table 75. Merit Medical Business Overview Table 76. Merit Medical TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merit Medical TACE Embolic Microspheres Product Portfolio Table 78. Merit Medical Recent Development Table 79. Mermaid Medical Company Information Table 80. Mermaid Medical Business Overview Table 81. Mermaid Medical TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Mermaid Medical TACE Embolic Microspheres Product Portfolio Table 83. Mermaid Medical Recent Development Table 84. Sirtex Medical Company Information Table 85. Sirtex Medical Business Overview Table 86. Sirtex Medical TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sirtex Medical TACE Embolic Microspheres Product Portfolio Table 88. Sirtex Medical Recent Development Table 89. Terumo Company Information Table 90. Terumo Business Overview Table 91. Terumo TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Terumo TACE Embolic Microspheres Product Portfolio Table 93. Terumo Recent Development Table 94. Varian Company Information Table 95. Varian Business Overview Table 96. Varian TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Varian TACE Embolic Microspheres Product Portfolio Table 98. Varian Recent Development Table 99. Cardiolink Science Company Information Table 100. Cardiolink Science Business Overview Table 101. Cardiolink Science TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Cardiolink Science TACE Embolic Microspheres Product Portfolio Table 103. Cardiolink Science Recent Development Table 104. Suzhou Hengrui Medical Equipment Company Information Table 105. Suzhou Hengrui Medical Equipment Business Overview Table 106. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio Table 108. Suzhou Hengrui Medical Equipment Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. TACE Embolic Microspheres Distributors List Table 112. TACE Embolic Microspheres Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. TACE Embolic Microspheres Product Image Figure 2. Global TACE Embolic Microspheres Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TACE Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 4. Global TACE Embolic Microspheres Sales (2021-2032) & (K Units) Figure 5. Global TACE Embolic Microspheres Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global TACE Embolic Microspheres Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Common Embolic Microspheres Image Figure 10. Drug-Loadable Embolic Microspheres Image Figure 11. Global TACE Embolic Microspheres Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global TACE Embolic Microspheres Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global TACE Embolic Microspheres Sales Volume Share by Type (2021-2032) Figure 14. Global TACE Embolic Microspheres Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global TACE Embolic Microspheres Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global TACE Embolic Microspheres Sales Value Share by Type (2021-2032) Figure 17. Colorectal Cancer Liver Metastasis Image Figure 18. Primary Liver Cancer Image Figure 19. Others Image Figure 20. Global TACE Embolic Microspheres Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global TACE Embolic Microspheres Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global TACE Embolic Microspheres Sales Volume Share by Application (2021-2032) Figure 23. Global TACE Embolic Microspheres Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global TACE Embolic Microspheres Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global TACE Embolic Microspheres Sales Value Share by Application (2021-2032) Figure 26. Global TACE Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global TACE Embolic Microspheres Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global TACE Embolic Microspheres Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global TACE Embolic Microspheres Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America TACE Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 31. North America TACE Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe TACE Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 33. Europe TACE Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific TACE Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific TACE Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America TACE Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 37. South America TACE Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa TACE Embolic Microspheres Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa TACE Embolic Microspheres Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt TACE Embolic Microspheres Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. TACE Embolic Microspheres Value Chain Figure 125. Manufacturing Cost Structure Figure 126. TACE Embolic Microspheres Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Common Embolic Microspheres
  • Drug-Loadable Embolic Microspheres
Applications
  • Colorectal Cancer Liver Metastasis
  • Primary Liver Cancer
  • Others
Companies covered
  • ABK Biomedical
  • Boston Scientific
  • Merit Medical
  • Mermaid Medical
  • Sirtex Medical
  • Terumo
  • Varian
  • Cardiolink Science
  • Suzhou Hengrui Medical Equipment

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global TACE Embolic Microspheres Sales Value (2021-2032)
  4. 1.2.2 Global TACE Embolic Microspheres Sales Volume (2021-2032)
  5. 1.2.3 Global TACE Embolic Microspheres Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 TACE Embolic Microspheres Market Dynamics
  1. 2.1 TACE Embolic Microspheres Industry Trends
  2. 2.2 TACE Embolic Microspheres Industry Drivers
  3. 2.3 TACE Embolic Microspheres Industry Opportunities and Challenges
  4. 2.4 TACE Embolic Microspheres Industry Restraints
3 TACE Embolic Microspheres Market by Company
  1. 3.1 Global TACE Embolic Microspheres Company Revenue Ranking in 2025
  2. 3.2 Global TACE Embolic Microspheres Revenue by Company (2021-2026)
  3. 3.3 Global TACE Embolic Microspheres Sales Volume by Company (2021-2026)
  4. 3.4 Global TACE Embolic Microspheres Average Price by Company (2021-2026)
  5. 3.5 Global TACE Embolic Microspheres Company Ranking (2024-2026)
  6. 3.6 Global TACE Embolic Microspheres Company Manufacturing Base and Headquarters
  7. 3.7 Global TACE Embolic Microspheres Company Product Type and Application
  8. 3.8 Global TACE Embolic Microspheres Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global TACE Embolic Microspheres Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 TACE Embolic Microspheres Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 TACE Embolic Microspheres Market by Type
  1. 4.1 TACE Embolic Microspheres Type Introduction
  2. 4.1.1 Common Embolic Microspheres
  3. 4.1.2 Drug-Loadable Embolic Microspheres
  4. 4.2 Global TACE Embolic Microspheres Sales Volume by Type
  5. 4.2.1 Global TACE Embolic Microspheres Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global TACE Embolic Microspheres Sales Volume by Type (2021-2032)
  7. 4.2.3 Global TACE Embolic Microspheres Sales Volume Share by Type (2021-2032)
  8. 4.3 Global TACE Embolic Microspheres Sales Value by Type
  9. 4.3.1 Global TACE Embolic Microspheres Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global TACE Embolic Microspheres Sales Value by Type (2021-2032)
  11. 4.3.3 Global TACE Embolic Microspheres Sales Value Share by Type (2021-2032)
5 TACE Embolic Microspheres Market by Application
  1. 5.1 TACE Embolic Microspheres Application Introduction
  2. 5.1.1 Colorectal Cancer Liver Metastasis
  3. 5.1.2 Primary Liver Cancer
  4. 5.1.3 Others
  5. 5.2 Global TACE Embolic Microspheres Sales Volume by Application
  6. 5.2.1 Global TACE Embolic Microspheres Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global TACE Embolic Microspheres Sales Volume by Application (2021-2032)
  8. 5.2.3 Global TACE Embolic Microspheres Sales Volume Share by Application (2021-2032)
  9. 5.3 Global TACE Embolic Microspheres Sales Value by Application
  10. 5.3.1 Global TACE Embolic Microspheres Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global TACE Embolic Microspheres Sales Value by Application (2021-2032)
  12. 5.3.3 Global TACE Embolic Microspheres Sales Value Share by Application (2021-2032)
6 TACE Embolic Microspheres Regional Sales and Value Analysis
  1. 6.1 Global TACE Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global TACE Embolic Microspheres Sales by Region (2021-2032)
  3. 6.2.1 Global TACE Embolic Microspheres Sales by Region: 2021-2026
  4. 6.2.2 Global TACE Embolic Microspheres Sales by Region (2027-2032)
  5. 6.3 Global TACE Embolic Microspheres Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global TACE Embolic Microspheres Sales Value by Region (2021-2032)
  7. 6.4.1 Global TACE Embolic Microspheres Sales Value by Region: 2021-2026
  8. 6.4.2 Global TACE Embolic Microspheres Sales Value by Region (2027-2032)
  9. 6.5 Global TACE Embolic Microspheres Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America TACE Embolic Microspheres Sales Value (2021-2032)
  12. 6.6.2 North America TACE Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe TACE Embolic Microspheres Sales Value (2021-2032)
  15. 6.7.2 Europe TACE Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific TACE Embolic Microspheres Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific TACE Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America TACE Embolic Microspheres Sales Value (2021-2032)
  21. 6.9.2 South America TACE Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa TACE Embolic Microspheres Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa TACE Embolic Microspheres Sales Value Share by Country, 2025 VS 2032
7 TACE Embolic Microspheres Country-level Sales and Value Analysis
  1. 7.1 Global TACE Embolic Microspheres Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global TACE Embolic Microspheres Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global TACE Embolic Microspheres Sales by Country (2021-2032)
  4. 7.3.1 Global TACE Embolic Microspheres Sales by Country (2021-2026)
  5. 7.3.2 Global TACE Embolic Microspheres Sales by Country (2027-2032)
  6. 7.4 Global TACE Embolic Microspheres Sales Value by Country (2021-2032)
  7. 7.4.1 Global TACE Embolic Microspheres Sales Value by Country (2021-2026)
  8. 7.4.2 Global TACE Embolic Microspheres Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt TACE Embolic Microspheres Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt TACE Embolic Microspheres Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt TACE Embolic Microspheres Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ABK Biomedical
  2. 8.1.1 ABK Biomedical Company Information
  3. 8.1.2 ABK Biomedical Business Overview
  4. 8.1.3 ABK Biomedical TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
  6. 8.1.5 ABK Biomedical Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Merit Medical
  14. 8.3.1 Merit Medical Company Information
  15. 8.3.2 Merit Medical Business Overview
  16. 8.3.3 Merit Medical TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
  18. 8.3.5 Merit Medical Recent Developments
  19. 8.4 Mermaid Medical
  20. 8.4.1 Mermaid Medical Company Information
  21. 8.4.2 Mermaid Medical Business Overview
  22. 8.4.3 Mermaid Medical TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
  24. 8.4.5 Mermaid Medical Recent Developments
  25. 8.5 Sirtex Medical
  26. 8.5.1 Sirtex Medical Company Information
  27. 8.5.2 Sirtex Medical Business Overview
  28. 8.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
  30. 8.5.5 Sirtex Medical Recent Developments
  31. 8.6 Terumo
  32. 8.6.1 Terumo Company Information
  33. 8.6.2 Terumo Business Overview
  34. 8.6.3 Terumo TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Terumo TACE Embolic Microspheres Product Portfolio
  36. 8.6.5 Terumo Recent Developments
  37. 8.7 Varian
  38. 8.7.1 Varian Company Information
  39. 8.7.2 Varian Business Overview
  40. 8.7.3 Varian TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Varian TACE Embolic Microspheres Product Portfolio
  42. 8.7.5 Varian Recent Developments
  43. 8.8 Cardiolink Science
  44. 8.8.1 Cardiolink Science Company Information
  45. 8.8.2 Cardiolink Science Business Overview
  46. 8.8.3 Cardiolink Science TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
  48. 8.8.5 Cardiolink Science Recent Developments
  49. 8.9 Suzhou Hengrui Medical Equipment
  50. 8.9.1 Suzhou Hengrui Medical Equipment Company Information
  51. 8.9.2 Suzhou Hengrui Medical Equipment Business Overview
  52. 8.9.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
  54. 8.9.5 Suzhou Hengrui Medical Equipment Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 TACE Embolic Microspheres Value Chain Analysis
  2. 9.1.1 TACE Embolic Microspheres Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 TACE Embolic Microspheres Sales Mode & Process
  6. 9.2 TACE Embolic Microspheres Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 TACE Embolic Microspheres Distributors
  9. 9.2.3 TACE Embolic Microspheres Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst